Fig. 5From: Change of ranibizumab-induced human vitreous protein profile in patients with proliferative diabetic retinopathy based on proteomics analysisIntravitreal level of a APOC1, b SERPINA5, c TIMP1, d KRT1 was confirmed by ELISA. **P < 0.01 between each groupBack to article page